Lifestyle interventions to prevent diabetes and cardiovascular by hkksew3563rd


									      Lifestyle interventions to prevent
diabetes and cardiovascular disease in
                                           Dr Kathryn Hart RD
                                Division of Nutritional Sciences
                       Faculty of Health and Medical Sciences

      In collaboration with Dr Yvonne Jeanes & Suzanne Barr at
                                        Roehampton University
Presentation outline

• Multi-organ, multi-symptom, multi-stage
• Risk profile of PCOS sufferers
• Current lifestyle practices
  – Diet, exercise & alternative therapies
• Recommended lifestyle practices
  – Management of weight, central obesity &
    insulin resistance
PCOS – a multi-organ syndrome




                                               adrenals      excess
obesity                                                     androgens
     adipose                  infertility
      tissue                                                 menstrual
                                              Abnormal      disturbances
            Insulin                         gonadotrophin
          resistance                          dynamics


                                               adrenals      excess
obesity                                                     androgens
     adipose                  infertility
      tissue                                                 menstrual
                                              Abnormal      disturbances
            Insulin                         gonadotrophin
          resistance                          dynamics
(Adapted from Moran
& Norman, 2004 &
Hopkinson et al., 1998)
                                      Insulin resistance
                                       Central obesity

                      Endocrine                             Metabolic
                     manifestations                        manifestations

                          ↑ insulin
             liver        ovary        adrenal     hypertension         dyslipidaemia
     ↓ SHBG

                ↑ androgen activity
                                                              long term
 “Our aim here is to emphasize that women
  with PCOS should no longer be regarded
 as merely having reproductive or cosmetic
problems, but as having a metabolic disorder
  that potentially puts them at high risk for
  developing diabetes and heart disease.”

                             Sharma & Nestler, 2006
CVD risk profile          dysfunction

    Chronic low grade             Hypertension
                                        Impaired cardiopulmonary
    - ↑CRP                              functional capacity
    -↑WBC’s                             - ↑ Heart rate recovery

                 ↑PAI-1                                     excess
 obesity                                                   androgens

                                           Abnormal lipid profile
                                           - ↓ HDL
               Insulin                     - ↑ LDL (inc ↑ sml dense LDL)
             resistance                    - ↑ Triglycerides

                                          (see Giallauria et al 2008; Liepa et al
                                        2008; Westerveld et al 2008; Sharma &
                                                                   Nestler 2006)
CVD risk profile        dysfunction

    Chronic low grade           Hypertension
                                      Impaired cardiopulmonary
    - ↑CRP                            functional capacity
    -↑WBC’s                           - ↑ Heart rate recovery

               ↑PAI-1                                  excess
 obesity                                              androgens

                                        Abnormal lipid profile
                                        - ↓ HDL
             Insulin                    - ↑ LDL (inc ↑ sml dense LDL)
           resistance                   - ↑ Triglycerides
CVD risk profile                 dysfunction

    Chronic low grade                    Hypertension
                                               Impaired cardiopulmonary
    - ↑CRP                                     functional capacity
    -↑WBC’s                 ↑ Thrombosis       - ↑ Heart rate recovery

                          ↑ Subclinical                          excess
 obesity             atherosclerotic disease                    androgens
                          ↑ Early onset CVD
                                                 Abnormal lipid profile
                                                 - ↓ HDL
               Insulin                           - ↑ LDL (inc ↑ sml dense LDL)
             resistance                          - ↑ Triglycerides

                                                (Sharma & Nestler 2006, Talbott et al
                                                             2000, Wild et al 1985)
Diabetes risk profile


Diabetes risk profile

                        ↑ impaired glucose

 obesity                ↑Early onset T2DM
                             ↑ T2DM
                        ↑Conversion IGT →                   menstrual
                             T2DM                          disturbances

                                            (Liepa et al 2008; Legro et al 2005;
                                        Norman et al 2001; Ehrmann et al 1999;
                                                               Legro et al 1999)
Multi-organ/ symptom/ stage
• Focus on reducing long term risk as well as
  managing current symptoms
         ..this complex and multifaceted disease requires a
  comprehensive approach in order to achieve concrete beneficial
  effects for PCOS patients. Multidisciplinary programs, including
   dietary, and educational counselling, exercise training, stress
  management and psychosocial support, might represent the gold
                                                    Giallauria et al 2008

          • Majority of endocrinologists and gynaecologists believe
          that the first line of treatment for all presentations of PCOS
          should be diet & exercise (Cussons et al 2005)
Multi-organ/ symptom/ stage
• Focus on reducing long term risk as well as
  managing current symptoms

      Diet     Exercise    Psychological   +/-   Pharmacological Rx

       Lifestyle therapy
Aims of lifestyle intervention
                    Overweight/ obese?

         Yes                                No

      ↓ weight
                                      Central obesity?
    Initial 5-10%
     Long term               Yes                             No
   maintenance of
      10-20%              ↓ waist
                                                         IGT/ Insulin

                                            ↑ insulin
What management strategies are
wPCOS using?

• Postal survey – strategies used & benefits
  – Exercise
     • 48% (100/208) reported increasing exercise to
       manage their condition with a further 2% (5/208)
       attempting to reduce stress
     • Of these women 80% (86/107) believed these
       lifestyle changes had improved their symptoms,
       15% (16/107) reported no change and only 2
       women (2%) felt their condition had worsened
– Exercise
                                                                      Percentage of
    • Current activity levels                vigorous                  time spent in
                                                                    physical activity,
                                          m oderate
                                                                         by intensity
                                                                          (n=194, postal

                                                         light activity

 Time (mins) spent in moderate or vigorous activity
 (n=194, postal survey)

mean steps/d





                       whole sample (n=38)   <25.0 kg/m2 (n=24)   >=25.0 kg/m2 (n=14)

                                               BMI group
                       Mean steps per day (n=38, observational study)
– Exercise
  • Current activity levels
     – Self reported exercisers not significantly more
       active than others, although trend towards
       increased time spent in vigorous activity (12.04
       [28.1] mins ‘v’ 5.74 [11.0], Z= -1.8, p=0.07)

     – Step counts negatively correlated with waist
       measurement (r = -0.36, p=0.03) and positively
       correlated with HDL (r = 0.54, p=0.001)
     – Trend towards a correlation with %body fat
       (r = -0.31, p=0.07)
– Alternative therapies
  • 41% (85/208) reported using some form of natural
    remedy or supplement with 54% perceiving an























                                         t iv







      Natural remedies and supplements taken by women with PCOS
       – Dietary strategies:
            • 55% were following a specific diet to manage their

                                                     Low GI 49%
Food avoidance (e.g.
                                                     Other 26%
   wheat) modified
protein & fruit intakes                              Low fat 10%

                                                     Reduced sugar 9%

                                                     Healthy Eating 6%

                    Dietary strategies employed by women with PCOS
What should they be using?
• Weight management
  – NICE (2006)
     • Use multi-component interventions (behavioural change,
       activity/ inactivity, energy intake, diet quality)
     • Assess readiness to change & explore barriers to change
     • Provide tailored advice

  – National Obesity Forum (2006)
     • First line: achieve 500kcal deficit through changes in diet &
       physical activity
     • Second line: consider drug treatments, behavioural therapy,
       alternative therapies, specialist obesity clinic, surgery

           • Focus on maintenance not just loss
           – successful maintainers = low fat diet, regular self
           monitoring, high physical activity (Wing & Hill 2001)
 What should they be using?
                          May → greater wt              Sig ↓ BMI ‘v’
                          loss than exercise               control
                             (10% ‘v’ 5%)               (Vigorito et al
           Diet alone                                       2007)
                             (Palomba et al
Range of dietary                                          Exercise
interventions →                                            alone
5-15% ↓ wt                    Weight management
(Moran et al 2008)                in wPCOS

       ↓6.3-10.2kg in 6mths
       (Clark et al 1995 & 1998)    (exercise, diet &   NB. Generally
                                       behaviour)       uncontrolled
 What should they be using?

• Reducing central obesity
  – Exercise
    • Higher levels of physical activity associated with
      ↓central fat (cross sectional & intervention) (Kim et al.,
      2008; Samaras & Campbell, 1997)

    • ↓ waist (0.2-2.9cm) seen in overweight women in
      long term physical activity interventions (time >
      intensity) (Lau et al 2007)
    • Interval training and progressive resistance training
      have positive effects on trunk fat in T2DM which
      may be indep of body mass (Kay & Fiatarone Singh, 2006)
 What should they be using?

• Reducing central obesity
  – Exercise (continued)
    • Aerobic & resistance exercise may affect fat stores
      via different methods (Van Etten et al 1995) BUT resistance
      exercise may have practical benefits over aerobic
    • Moderate & high intensive exercise shown to be
      effective for reducing abdominal fat but
      ? effectiveness of lower intensities (Kay & Fiatarone Singh,
What should they be using?

• Reducing central obesity
  – Diet
    • MUFA rich diets (‘v’ CHO rich) associated with ↓
      central fat redistribution (Paniagua et al., 2007)
    • Potential role of high dairy calcium in promoting fat
      loss independent of weight loss (e.g. Zemel et al 2005)
    • Higher wholegrain intakes associated with lower
      central adiposity in cross sectional studies (Harland &
      Garton 2008)

    • Wholegrain enriched hypocaloric diet → sig
      ↓abdominal fat ‘v’ refined grain diet in obese adults
      with Metabolic Syndrome (Katcher et al 2008)
What should they be using?
                        ↓ central obesity in

              Diet +
   20wk hypocaloric
                        12 week programme       3-6mth structured
  diet +/- exercise →
                            of nutrition or          exercise
  sig ↓waist (11%).
                         nutrition + exercise      programmes
  + Exercise → 45%      → sig ↓waist (~5%).      (aerobic) → sig
  greater ↓ body fat                             greater ↓waist
                          12%↓ skinfold
    ‘v’ diet alone                              circumference ‘v’
                            thickness in
 (Thomson et al 2008)   combined approach          control/ diet
                        ‘v’ 3% in diet alone    (Vigorito et al 2007,
                          No sig ↓weight        Palomba et al 2008)

                          (Bruner et al 2006)
What should they be using?

• Increasing insulin sensitivity
  – Exercise
     • acute exercise and training→ ↑ insulin sensitivity of
       skeletal muscle & ↑ glucose tolerance and insulin
     • short term effects of exercise seen independent of
       changes in adiposity
     • Resistance training → improved muscle quality
       (strength & fibre composition) → ↑glucose uptake
       (Brooks et al., 2007)

     • regular physical activity may prevent or delay
     development of T2DM (indep. of starting BMI), e.g. DaQuing
• Increasing insulin sensitivity
  – Exercise
     • protective effect of physical activity strongest for
      individuals at highest risk of developing T2DM
      (Barwell et al 2008, Ivy 1997)
What should they be using?

• Increasing insulin sensitivity
  – Diet
     1. FAT
     • High MUFA (‘v’ high SFA) significantly improves
       insulin sensitivity in healthy, obese & T2DM (Vessby et al
      2001, Summers et al 2003)

     • ↑ total fat → ↓ insulin sensitivity BUT mediated by
     • Increase in total fat from 20% → 40% energy has NO
       impact on insulin sensitivity when corrected for wt.
      (Ricardi & Rivellese, 2000)
• Increasing insulin sensitivity
  – Diet
     2. Carbohydrate (Volek & Feinman, 2005)
     • Quality – lower GI/ GL
     • Quantity - reduced CHO (even without wt loss or in
       comparison to low fat) can have positive impact on
       fasting & post challenge insulin (Douglas et al 2006)
        • Replace CHO with…nothing or MUFA or protein
        • ~40% CHO (from 55%), very low carbohydrate diets
          not necessary
     • Wholegrains → ↓postprandial glucose due to slower
       digestion & absorption (Kaline et al 2007)
     • ↑ dietary fibre intakes associated with ↑insulin
       sensitivity (Liese et al 2005)
• Increasing insulin sensitivity
  – Diet
     3. Supplements
     • Chromium
        • may ↑insulin sensitivity in T2DM (Martin et al., 2006)
        • ? deficiency associated with insulin resistance (Diabetes
           Education, 2004)

     • Vitamin D replenishment improves glycaemia &
       insulin secretion in T2DM (Palomer et al 2008)
     • Inconclusive evidence for the effect of cinnamon on
       insulin resistance – may have a moderate effect in
       lowering plasma glucose in poorly controlled T2DM
      (Pham et al 2007)
 What should they be using?
                            V low CHO →
        Diet                   ↓insulin
                            (Hays et al 2003)
  Higher protein →
    ↓postprandial                                                  6mth structured
   glucose (‘v’ low                                             exercise → 41% ↓IR
       protein)                                                independent of weight
                                                                 loss (‘v’ 9% for diet
  (Moran et al 2003)         ↑ Insulin sensitivity in                   alone)
                                    wPCOS                       (Palomba et al 2008)

NB. All overwt/ obese
Some uncontrolled +/-
small samples

               Cinnamon extract       Chromium may ↑        Vit D supplementation
                 may ↓ insulin        glucose disposal      → ↑insulin secretion &
                  resistance                rate            improved lipid profile
               (Wang et al 2007)       (Lydic et al 2006)      (Kotsa et al 2008)
What should they be using?

• Summary
  – Exercise recommendations
     • Exercise of benefit across PCOS population BUT ?
       Type/ duration & intensity
     • Aim for adherence over intensity
     • General population guidelines remain appropriate
       (and sufficiently challenging!) targets for many, e.g.
       30mins, 5x week
     • Promote global and concrete benefits, e.g. ↓stress,
       ↑self esteem, ↓waist
     • Emphasise benefits for increase/ maintenance of
       LBM, esp. for those aiming to lose weight
What should they be using?

• Summary
  – Diet recommendations
     • Low saturated fat (<10%) (replace with MUFA) and
       low-moderate total fat (<30-37% energy)
     • High fibre/ wholegrain carbohydrate choices
     • 20% E from protein, increased (with ↓CHO) if
       required for satiety/ wt control
     • Energy restriction for weight loss (200-500kcal/d)
     • Adequate intake of n3 fats, e.g. 1-2 portions/ wk
       oily fish (or fish oil/ flaxseed oil)
     • Adequate intake of Vitamin D and calcium
What should they be using?

• Summary
  – General recommendations
     • Avoid ‘scale obsession’ - improvements in
       abdominal obesity and insulin sensitivity may occur
       without significant ↓wt
     • ‘standard practice’ ‘v’ ‘specialised practice’ - if
       overweight or obese → effective weight loss
       strategies as 1st line treatment
     • Psychological & social support – importance in
       non-PCOS weight loss/ behaviour change
       recognised and suggestion that psychological
       ‘need’ may be even greater in PCOS

• Therapeutic management of PCOS must
  recognise it multi-organ, multi-feature, multi-
  stage nature.
• Substantial evidence from the insulin resistance/
  diabetes literature can be translated into
  appropriate interventions for the PCOS
• Further robust research is needed within the
  lean PCOS population specifically to fill in the
  gaps where more specialised approaches may
  be warranted.

  Dr Yvonne Jeanes & Suzanne Barr (Roehampton)

  Internal funding from University of Surrey & Roehampton University

  All students and technical staff who have assisted with the studies

  All women who have participated in the research
•   Barwell ND, Malkova D, Moran CN et al (2008) Exercise training has greater effects
    on insulin sensitivity in daughters of patients with type 2 diabetes than in women with
    no family history of diabetes. Diabetologia. 51(10): 1912-9.
•   Brooks N, Layne JE, Gordon PL, Roubenoff R, Nelson ME, Castaneda-Sceppa C
    (2006) Strength training improves muscle quality and insulin sensitivity in Hispanic
    older adults with type 2 diabetes. Int J Med Sci. 18;4(1): 19-27.
•   Bruner B, Chad K, Chizen D (2006) Effects of exercise and nutritional counseling in
    women with polycystic ovary syndrome. Appl Physiol Nutr Metab 31: 384–91.
•   Clark AM, Ledger W, Galletly C et al (1995) Weight loss results in significant
    improvement in pregnancy and ovulation rates in anovulatory obese women. Hum
    Reprod 10: 2705–12.
•   Clark AM, Thornley B, Tomlinson L et al (1998) Weight loss in obese infertile women
    results in improvement in reproductive outcome for all forms of fertility treatment.
    Hum Reprod 13: 1502–5.
•   Cussons AJ, Stuckey BG, Walsh JP et al. (2005) Polycystic ovarian syndrome:
    marked differences between endocrinologists and gynaecologists in diagnosis and
    management. Clinical Endocrinology 62: 289–295.
•   Diabetes Education (2004) A scientific review: the role of chromium in insulin
    resistance. Diabetes Education. Suppl:2-14.
•   Douglas CC, Gower BA, Darnell BE et al. (2006) Role of diet in the treatment of
    polycystic ovary syndrome. Fertility and Sterility 85: 679 – 688.
•   Ehrmann DA, Barnes RB, Rosenfield RL et al. (1999) Prevalence of impaired glucose
    tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care
    22(1): 141–146.
•   Giallauria F, Palomba S, Maresca L et al. (2008) Exercise training improves
    autonomic function and inflammatory pattern in women with polycystic ovary
    syndrome (PCOS) Clinical Endocrinology 69: 792–798
•   Harland JI, Garton LE. (2008) Whole-grain intake as a marker of healthy body weight
    and adiposity. Public Health Nutr. 11(6):554-63.
•   Hays JH, DiSabatino A, Gorman RT et al (2003) Effect of a high saturated fat and no-
    starch diet on serum lipid subfractions in patients with documented atherosclerotic
    cardiovascular disease. Mayo Clin Proc 78: 1331–6.
•   Hopkinson ZE, Sattar N, Fleming R, Greer IA (1998) Polycystic ovarian syndrome:
    the metabolic syndrome comes to gynaecology. British Medical Journal 317(7154):
•   Ivy JL (1997) Role of exercise training in the prevention and treatment of insulin
    resistance and non-insulin-dependent diabetes mellitus. Sports Med. 24(5): 321-36.
•   Kaline K, Bornstein SR, Bergmann A, Hauner H, Schwarz PE. (2007) The importance
    and effect of dietary fiber in diabetes prevention with particular consideration of whole
    grain products. Horm Metab Res. 39(9):687-93.
•   Katcher HI, Legro RS, Kunselman AR et al (2008) The effects of a whole grain-
    enriched hypocaloric diet on cardiovascular disease risk factors in men and women
    with metabolic syndrome. Am J Clin Nutr. 87(1):79-90.
•   Kay SJ & Fiatarone Singh MA (2006) The infleunce of physical activity on abdominal
    fat: a systeatic review of the literature. Obesity Reviews 7: 183-200.
•   Kim K, Valentine RJ, Shin Y, Gong K (2008) Associations of visceral adiposity and
    exercise participation with C-reactive protein, insulin resistance, and endothelial
    dysfunction in Korean healthy adults. Metabolism 57(9):1181-9.
•   Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2008) Role of vitamin D
    treatment in glucose metabolism in polycystic ovary syndrome. Fertility & Sterility. Oct
•   Lau DCW, Douketis JD, Morrison KM et al (2007) 2006 Canadian clinical practice
    guidelines on the management and prevention of obesity in adults and children.
    CMJA; 176 (8 Suppl): 1-117
•   Legro RS, Kunselman AR, Dodson WC & Dunaif A. (1999) Prevalence and predictors
    of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary
    syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical
    Endocrinology and Metabolism 84(1): 165–169.
•   Legro RS, Gnatuk CL, Kunselman AR & Dunaif A. (2005) Changes in glucose
    tolerance over time in women with polycystic ovary syndrome: a controlled study.
    Journal of Clinical Endocrinology and Metabolism 90(6): 3236–3242.
•   Liepa GU, Sengupta A, Karsies D (2008) Polycystic Ovary Syndrome (PCOS) and
    Other Androgen Excess-Related Conditions: Can Changes in Dietary Intake Make a
    Difference? Nutrition in Clinical Practice 23: 63–71,
•   Liese AD, Schulz M, Fang F, Wolever TM, D'Agostino RB Jr, Sparks KC, Mayer-
    Davis EJ. (2005) Dietary glycemic index and glycemic load, carbohydrate and fiber
    intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin
    Resistance Atherosclerosis Study. Diabetes Care 28(12): 2832-8.
•   Lucidi RS, Thyer AC, Easton CA et al (2005) Effect of chromium supplementation on
    insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary
    syndrome. Fertility & Sterility 84: 1755–1757.
•   Lydic ML, McNurlan M, Bembo S et al (2006) Chromium picolinate improves insulin
    sensitivity in obese subjects with polycystic ovary syndrome. Fertility & Sterility 86:
•   Martin J, Wang ZQ, Zhang XH et al (2006) Chromium picolinate supplementation
    attenuates body weight gain and increases insulin sensitivity in subjects with type 2
    diabetes. Diabetes Care. 29(8):1826-32.
•   Moran LJ, Noakes M, Clifton PM et al (2003) Dietary composition in restoring
    reproductive and metabolic physiology in overweight women with polycystic ovary
    syndrome. J Clin Endocrinol Metab 88: 812–9.
•   Moran L, Norman RJ (2004) Understanding and managing disturbances in insulin
    metabolism and body weight in women with polycystic ovary syndrome. Best Practice
    & Research in Clinical Obstetrics and Gynaecology 18(5): 719-736
•   Moran LJ, Pasquali R, Teede HJ et al (2008) Treatment of obesity in polycystic ovary
    syndrome: a position statement of the Androgen Excess and Polycystic Ovary
    Syndrome Society. Fertility & Sterility.
•   National Obesity Forum (2006) Guidelines on Management of Adult Obesity and
    Overweight in Primary Care.
•   NICE (2006) Obesity guidance on the prevention, identification, assessment and
    management of overweight and obesity in adults and children.
•   Norman RJ, Masters L, Milner CR et al. (2001) Relative risk of conversion from
    normoglycemia to impaired glucose tolerance or non-insulin dependent diabetes
    mellitus in polycystic ovarian syndrome. Human Reproduction 16(9): 1995–1998.
•   Palomba S, Giallauria F, Falbo A et al (2008) Structured exercise training programme
    versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with
    anovulatory infertility: a 24-week pilot study. Hum Reprod 23: 642–50.
•   Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of
    vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obesity &
    Metabolism. 10(3):185-97.
•   Paniagua JA, Gallego de la Sacristana A, Romero I, et al (2007) Monounsaturated
    fat-rich diet prevents central body fat distribution and decreases postprandial
    adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant
    subjects. Diabetes Care; 30(7): 1717-23.
•   Pham AQ, Kourlas H, Pham DQ (2007) Cinnamon supplementation in patients with
    type 2 diabetes mellitus. Pharmacotherapy. 27(4):595-9.
•   Riccardi G & Rivellese AA (2000) Dietary treatment of the metabolic syndrome – the
    optimal diet. British Journal of Nutrition, 83, Suppl. 1, S143–S148
•   Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S (1998) The metabolically
    obese, normal-weight individual revisited. Diabetes. 47(5): 699-713.
•   Samaras K, Campbell LV (1997) The non-genetic determinants of central adiposity.
    Int J Obes Relat Metab Disord ; 21(10): 839-45.
•   Sharma ST, Nestler JE (2006) Prevention of diabetes and cardiovascular
•   disease in women with PCOS: Treatment with insulin sensitizers Best Practice &
    Research Clinical Endocrinology & Metabolism 20(2): 245–260
•   Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. (2000) Evidence for association
    between polycystic ovary syndrome and premature carotid atherosclerosis in middle
    aged women. Arterioscler Thromb Vasc Biol 20:2414–2421.
•   Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD (2008)
    The effect of a hypocaloric diet with and without exercise training on body
    composition, cardiometabolic risk profile, and reproductive function in overweight and
    obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(9): 3373-
•   Van Etten LM, Westerterp KR, Verstappen FT (1995) Effect of weight-training on
    energy expenditure and substrate utilization during sleep. Medicine & Science in
    Sports & Exercise. 27:188–193.
•   Vessby B, Uusitupa M, Hermansen K et al (2001) Substituting dietary saturated for
    monounsaturated fat impairs insulin sensitivity in healthy men and women: The
    KANWU study. Diabetologia 44: 312 – 319.
•   Vigorito C, Giallauria F, Palomba S et al (2007) Beneficial effects of a three-month
    structured exercise training program on cardiopulmonary functional capacity in young
    women with polycystic ovary syndrome. J Clin Endocrinol Metab 92: 1379–84.
•   Volek JS, Feinman RD (2005) Carbohydrate restriction improves the features of
    Metabolic Syndrome. Metabolic Syndrome may be defined by the response to
    carbohydrate restriction. Nutr Metab; 2: 31.
•   Wang, J. et al. (2007). The effect of cinnamon extract on insulin resistance
    parameters in polycystic ovary syndrome: a pilot study." Fertility and Sterility 88: 240-
•   Westerveld HE, Hoogendoorn M, de Jong AW et al (2008) Cardiometabolic
    abnormalities in polycystic ovary syndrome: pharmacotherapeutic insights.
    Pharmacological Therapy 119(3): 223-241
•   Wild RA, Painter PC, Coulson PB et al (1985) Lipoprotein lipid concentrations and
    cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol
    Metab. 61:946–951.
•   Wing RR, Hill JO.(2001) Successful weight loss maintenance. Annual Reviews in
    Nutrition. 21:323-41.
•   Zemel MB, Richards J, Mathis S et al (2005) Dairy augmentation of total and central
    fat loss in obese subjects. Int J Obes. 29(4):391-7.
DaQuing Study
Exercise: ↑ daily leisure physical activity

                                              50% reduction in progression
                                              to T2DM with exercise +/- diet

                                                   Pan et al 1997, cited in Ruderman et
                                                   al., 1998
Why target this group?

                                                  Lack of National guidelines/ consistent
  Clinical need                   Personal need

                                                         management strategies

To top